Mimedx (MDXG) Free Cash Flow (2011 - 2026)

Mimedx has disclosed Free Cash Flow across 16 years of filings, most recently posting -$10.6 million for Q2 2026.

• In Q2 2026, Free Cash Flow fell 174.53% year-over-year to -$10.6 million; the TTM figure through Jun 2026 stood at $44.5 million (down 22.11% YoY), while the FY2025 annual figure was $73.0 million, up 11.5% from the prior year.
• Free Cash Flow came in at -$10.6 million for Q2 2026 at Mimedx, down from $1.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $29.1 million in Q3 2025 to a low of -$10.6 million in Q2 2026.
• Average Free Cash Flow over 5 years is $7.9 million, with a median of $7.2 million recorded in 2023.
• Year-over-year, Free Cash Flow sank 383.5% in 2022 and soared 1944.59% in 2023.
• Over 5 years, Free Cash Flow stood at -$6.3 million in 2022, then jumped by 240.57% to $8.8 million in 2023, then jumped by 109.41% to $18.5 million in 2024, then jumped by 33.23% to $24.7 million in 2025, then plunged by 143.02% to -$10.6 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$10.6 million in Q2 2026, $1.3 million in Q1 2026, and $24.7 million in Q4 2025.